PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham +21 more
wiley +1 more source
Correction to 'Small molecules inhibitors of the heterogeneous ribonuclear protein A18 (hnRNP A18): a regulator of protein translation and an immune checkpoint'. [PDF]
europepmc +1 more source
Effects of plant growth regulators on Orobanche coerulescens seed germination. [PDF]
Wang YH +6 more
europepmc +1 more source
A regulator gene that is dominant on an episome and recessive on a chromosome.
Alvin Markovitz, Nancy Rosenbaum
openalex +1 more source
Decrypting cancer's spatial code: from single cells to tissue niches
Spatial transcriptomics maps gene activity across tissues, offering powerful insights into how cancer cells are organised, switch states and interact with their surroundings. This review outlines emerging computational, artificial intelligence (AI) and geospatial approaches to define cell states, uncover tumour niches and integrate spatial data with ...
Cenk Celik +4 more
wiley +1 more source
<i>TBRG4</i> as a prognostic biomarker and key regulator of cell cycle and EMT in lung cancer. [PDF]
Wang A +9 more
europepmc +1 more source
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan +9 more
wiley +1 more source
Adapting to low phosphorus: Alterations in HvSPX4 expression levels in barley. [PDF]
Tsednee M.
europepmc +1 more source
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts +8 more
wiley +1 more source
Two-Component Response Regulators CitT, YvcP, and YycI Differentially Control Pectin and Hemicellulose Degradation in Degumming of Ramie Fibers by <i>Bacillus subtilis</i> Strain 168. [PDF]
Yang Q +9 more
europepmc +1 more source

